Objectives In 2011, a consensus was reached defining “late presenters” (LPs) as individuals presenting for care with a CD4 count < 350 cells/μL or with an AIDS-defining event, regardless of CD4 count. However, a transient low CD4 count is not uncommon in recent infections. The objective of this study was to investigate how measurements of late presentation change if the clinical stage at the time of diagnosis is taken into account. Methods Case surveillance data for newly diagnosed patients in Belgium in 1998–2012 were analysed, including CD4 count at diagnosis, the presence of AIDS-defining events, and recent infections (< 6 months) as reported by clinicians in the case of acute illness or a recent negative test. First, proportions of LPs...
<p>Adjusted additionally for age, region of origin, delayed entry into care (≥3 mo between HIV diagn...
Background: The aim of our study was to assess the extent of late presentation for HIV care in North...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...
<p><b>OBJECTIVES: </b>In 2011, a consensus was reached defining "late present...
In 2011, a consensus was reached defining "late presenters" (LPs) as individuals presenting for care...
International audienceIntroduction: In recent years, HIV testing frequency has increased, resulting ...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
OBJECTIVES: Across Europe, almost a third of individuals infected with HIV do not enter health care ...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), o...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
Introduction: Late HIV diagnosis is common and associated with an increased risk of clinical progres...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
A substantial proportion of HIV-infected individuals do not present for HIV testing until late in in...
<p>Adjusted additionally for age, region of origin, delayed entry into care (≥3 mo between HIV diagn...
Background: The aim of our study was to assess the extent of late presentation for HIV care in North...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...
<p><b>OBJECTIVES: </b>In 2011, a consensus was reached defining "late present...
In 2011, a consensus was reached defining "late presenters" (LPs) as individuals presenting for care...
International audienceIntroduction: In recent years, HIV testing frequency has increased, resulting ...
BACKGROUND: Antiretroviral therapy reduces mortality and morbidity in HIVinfected individuals, most ...
OBJECTIVES: Across Europe, almost a third of individuals infected with HIV do not enter health care ...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
In 2014, there were 36.9 million people worldwide living with human immunodeficiency virus (PLWH), o...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
<p>Late presentation: diagnosed with HIV with a CD4 count below 350/mm<sup>3</sup> or an AIDS defini...
Introduction: Late HIV diagnosis is common and associated with an increased risk of clinical progres...
Objectives: In Europe, 15-38% of individuals with HIV infection are diagnosed late in the course of ...
A substantial proportion of HIV-infected individuals do not present for HIV testing until late in in...
<p>Adjusted additionally for age, region of origin, delayed entry into care (≥3 mo between HIV diagn...
Background: The aim of our study was to assess the extent of late presentation for HIV care in North...
QUESTIONS UNDER STUDY We sought to identify reasons for late human immunodeficiency virus (HIV) t...